News

Search:

Will EMRs Drive Adoption of New Software Synchronization Abilities?

0 Likes

Keeping all of the time pieces in one’s house synchronized represents a challenge to even the most obsessive of timekeepers. Most devices—clocks, cell phones, cable boxes, cars and more—include an Read More...

Tags:

EMR

Medical Device

Patient Safety

Risks

Synchronization

time

Public Citizen to FDA: Diabetes Drug Unsafe, Should Be Pulled

0 Likes

The watchdog group Public Citizen is calling on the US Food and Drug Administration (FDA) to yank Novo Nordisk’s diabetes drug Victoza (liraglutide) off the market for safety risks it says “outweigh Read More...

Tags:

Diabetes

FDA

Liraglutide

Novo Nordisk

Public Citizen

Risks

Rosebraugh

Victoza

Wolfe

Sixteen Drugs Identified by AERS as Potentially Having Serious Risks

0 Likes

Sixteen drugs were identified by the Adverse Event Reporting System (AERS) during the fourth quarter of 2011 and have been flagged by the US Food and Drug Administration (FDA) for further review, the Read More...

Tags:

2011

AERS

FDA

REMS

Risks

Safety

RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

Most Viewed
Most Popular

Most Viewed

China's SFDA Becomes CFDA amidst Consolidation of Power and New Leadership 25 March 2013
FDA Plans Huge Cardiovascular Registry With Focus on Medical Devices 2 April 2013
In Unprecedented Shift, EU Parliament Proposes Premarket Authorization for Medical Devices 15 April 2013
Goodbye, KFDA: Korean Regulator Gets New Name, Decentralized Authority After Reorganization 28 March 2013
FDA Gets Go-Ahead for Study of DTC Advertising and Social Media 18 April 2013
UPDATED: President's Budget Proposal Calls for Small Increases at FDA, but Big Changes for Industry 11 April 2013
IBM Awarded Huge Contract to Modernize Regulatory Review Processes at FDA 29 April 2013
New FDA Document Clarifies IND Process for Drugs, Biologics and Biosimilars 30 April 2013

New Regulatory Focus Apps for iPad and iPhone

Stay Connected:

Regulatory Focus is for regulatory professionals written by regulatory professionals.

The publication takes a look at the important topics facing regulatory professionals in a changing global healthcare landscape. From topics ranging from research and development to labeling and marketing, the articles try to analyze, inform, and educate readers about the issues at the forefront of the industry.

Rated as the number one benefit by the members of RAPS, Regulatory Focus strives to provide the best and most current information to regulatory professionals so they can succeed and advance at every stage in their careers.

For questions or comments on our content or to find out more about Regulatory Focus, please visit our About RF page.

News

Will EMRs Drive Adoption of New Software Synchronization Abilities?

Public Citizen to FDA: Diabetes Drug Unsafe, Should Be Pulled

Sixteen Drugs Identified by AERS as Potentially Having Serious Risks

Get RF Today